Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-06-01
2008-10-28
Goldberg, Jeanine A (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200
Reexamination Certificate
active
07442509
ABSTRACT:
The invention pertains to methods for detecting the presence or absence of a mutation associated with hypertrophic cardiomyopathy in cats, particularly domesticated cats, and more particularly Maine Coon cats. The methods include detecting the presence or absence of a mutation in the feline MYBPC gene, and identifying feline subjects that have or are at risk of developing hypertrophic cardiomyopathy.
REFERENCES:
patent: 5912121 (1999-06-01), Seidman et al.
patent: 2003/0092019 (2003-05-01), Meyer et al.
patent: 2004/0086876 (2004-05-01), Seidman et al.
Meurs et al. Genomics, vol. 90, pp. 261-264, 2007.
Hirschhorn et al. (Genetics in Medicine. vol. 4, No. 2, pp. 45-61, Mar. 2002).
Ioannidis (Nature Genetics, vol. 29, pp. 306-309, Nov. 2001).
Tacher et al. (J. of Heredity, vol. 96, No. 7, pp. 812-816, 2005).
http://www.indys.org.uk/hcm.htm., Feb. 14, 2008.
Fananapazir et al., “Genotype-Phenotype Correlations in Hypertrophic Cardiomyopathy: Insights Provided by Comparisons of Kindreds With Distinct and Identical beta-Myosin Heavy Chain Gene Mutations,” Circulation. vol. 89, No. 1, Jan. 1994, pp. 22-32.
Kittleson et al., “Familial Hypertrophic Cardiomyopathy in Maine Coon Cats: An Animal Model of Human Disease,” Circulation, vol. 99, No. 24, Jun. 22, 1999, pp. 3172-3180.
Meurs et al., “A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy,” Human Molecular Genetics, (2005), vol. 14, No. 23, pp. 3587-3593.
Moolman et al., “A Newly Created Splice Donor Site in Exon 25 of the MyBP-C Gene Is Responsible for Inherited Hypertrophic Cardiomyopathy With Incomplete Disease Penetrance,” Circulation, vol. 101, No. 12, Mar. 28, 2000, pp. 1396-1402.
Reiser et al., “Electrophoretic separation and quantitation of cardiac myosin heavy chain isoforms in eight mammalian species,” Am J Physiol, vol. 274, No. (3 Pt 2), Mar. 1998, pp. H1048-H1053.
Richard et al., “Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy,” Circulation, vol. 107, No. 17, May 6, 2003, pp. 2227-2232.
Watkins et al., “Expression and Functional Assessment of a Truncated Cardiac Troponin T That Causes Hypertrophic Cardiomyopathy,” J. Clin. Invest., vol. 98, No. 11. Dec. 1996, pp. 2456-2461.
Winegrad, “Cardiac Myosin Binding Protein C,” Circulation Research, vol. 84, No. 10, May 28, 1999, pp. 1117-1126.
Winegrad, “Myosin Binding Protein C, a Potential Regulator of Cardiac Contractility,” Circulation Research, vol. 86, No. 1, Jan. 7-21, 2000, pp. 6-7.
Witt et al., “Hypercontractile Properties of Cardiac Muscle Fibers in a Knock-in Mouse Model of Cardiac Myosin-binding Protein-C,” J Biol Chem., vol. 276, No. 7, Feb. 16, 2001, pp. 5353-5359.
Kittleson Mark
Meurs Kathryn
Calfee Halter & Griswold LLP
Goldberg Jeanine A
The Ohio State University Research Foundation
University of California Davis
LandOfFree
Detecting mutations in the feline cardiac myosin binding... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detecting mutations in the feline cardiac myosin binding..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detecting mutations in the feline cardiac myosin binding... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3990181